🇺🇸 FDA
Patent

US 10130700

Polyvalent influenza virus-like particles (VLPS) and use as vaccines

granted A61KA61K2039/5258A61K2039/543

Quick answer

US patent 10130700 (Polyvalent influenza virus-like particles (VLPS) and use as vaccines) held by The United States of America, as represented by the Secretary, DHHS expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, DHHS
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/5258, A61K2039/543, A61K2039/55572, A61K2039/70